Papers
2
Total Citations
39
H-Index
2
About
Eui Kyu Chie is a leading radiation oncologist whose research has significantly advanced the treatment of gastrointestinal cancers and the precision of radiotherapy delivery. His major contributions center on optimizing chemoradiotherapy protocols for rectal cancer, most notably through a pivotal phase II multi-institutional clinical trial (KROG 11-02) that demonstrated the safety and efficacy of a two-week preoperative course followed by delayed surgery. This work, cited over 25 times, has helped shape modern neoadjuvant treatment strategies. In parallel, Chie has made critical contributions to radiotherapy quality assurance, particularly through his work on gamma analysis for stereotactic ablative radiotherapy (SABR). His study establishing a stringent 2%/1 mm gamma criterion for volumetric modulated arc therapy (VMAT) has been cited 14 times and provides a vital benchmark for ensuring treatment accuracy in high-precision radiation delivery. As a faculty member at Seoul National University, Chie continues to bridge clinical oncology and medical physics, driving innovations that improve both treatment outcomes and patient safety. His research remains essential reading for clinicians and physicists seeking to refine radiotherapy protocols in the era of precision medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2